THANK YOU FOR SUBSCRIBING
Clinical trials are now heavily digitized, allowing biotech firms to test treatments on more patients in less time.
FREMONT, CA: Biotechnology has always been centered on technology. However, emerging advanced computing technology, such as artificial intelligence and machine learning, allows companies to widen the scope and scale while also improving manufacturing efficiency, reducing the time it takes biotech companies to bring new products to market.
Five Emerging Trends in Biotechnology
Application of Next-Generation Computing Technology
The evolution of cloud computing technology has removed a barrier to many biotech innovations. The ability to run cloud applications enables businesses to store and analyze data without investing in costly computer hardware. This benefits early-stage startups, which strive to keep operating costs as low as possible.
The Evolution of Clinical Trials
Machine learning technology holds promise for the future of clinical trials as well. For example, biotech firms can quickly analyze data from current trials to predict treatment effectiveness down to the molecular level; they can also revisit data from previous attempts to see if anything was missed or new or different uses for an existing drug.
Growth in Personalized Treatment of Rare Diseases
Cancer treatment is a priority for targeted therapies. One prominent example is blood cancer, such as leukemia. According to the National Cancer Institute, a treatment known as CAR T-cell therapy targets a patient's immune cells, causing the immune system to "attack tumours," according to the National Cancer Institute.
Demand for Higher Agricultural Yields
These global trends present biotechnology with opportunities to improve agricultural yields. For example, gene editing could create wheat or corn varieties that can grow in harsher conditions or produce more grain in a smaller area than other crop varieties while providing the same nutritional value.
The Increasing Use of Monoclonal Antibodies
Monoclonal antibodies are laboratory-created antibodies intended to restore, enhance, or mimic an immune system response, particularly cancer cells. They can do everything from identifying cancer cells to delivering radiation to affected areas.